Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.
We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.